Top Markets
Coin of the day
NuGenerex Immuno-Oncology, Inc. NuGenerex Immuno-Oncology, Inc.

NuGenerex Immuno-Oncology, Inc.

NUGX
Clasificación en acciones #41797
NuGenerex Immuno-Oncology, Inc. is an oncology firm committed to treating... NuGenerex Immuno-Oncology, Inc. is an oncology firm committed to treating cancer through the strategic modulation of the immune system. The company's development pipeline includes a range of immunotherapeutic products and vaccines. Notably, it is advancing AE37, a peptide immunotherapeutic vaccine, which is currently undergoing Phase II clinical studies for metastatic triple-negative breast cancer. Founded in 1993 and headquartered in Miramar, Florida, the entity was formerly named Antigen Express, Inc. NuGenerex Immuno-Oncology, Inc. operates as a subsidiary of Generex Biotechnology Corporation.
Precio por acción
$0.0001
Última sincronización: 2023-05-22
Capitalización bursátil
$10.03K
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio NuGenerex Immuno-Oncology, Inc. (NUGX)

Categoría

Historial del precio de la acción de NuGenerex Immuno-Oncology, Inc. (NUGX)
Precio más alto de cierre: $0.00 el 2023-05-01

Precio más bajo de cierre: $1.44 el 2021-03-01
Historial del precio de la acción de NuGenerex Immuno-Oncology, Inc. desde 2021 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2023 75.00%
2022 -98.81%
2021 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$527.87 33.33%
US
$873.57 35.10%
NL
$736.38 7.69%
CH
$263.09 18.09%
BE
$1.08K -6.92%
KR